Literature DB >> 10972312

"Herbal Ecstasy": a case series of adverse reactions.

K M Yates1, A O'Connor, C A Horsley.   

Abstract

AIMS: To report five cases of adverse effects associated with the ingestion of "Herbal Ecstasy" tablets and discuss possible mechanisms of toxicity.
METHOD: Composition of the "Herbal Ecstasy" tablets was determined by discussions with distributors and with MEDSAFE: Reference to relevant texts and an internet and Medline literature search was used to identify articles of interest
RESULTS: Three patients complained of minor symptoms such as perceptual disturbances, anorexia, inability to sleep, dizziness, palpitations and paresthesia. A fourth patient presented with palpitations and ventricular bigeminy, and a fifth patient presented with headache, vomiting, and a hypertensive crisis. Different brands of "Herbal Ecstasy" have different compositions, some containing caffeine and kava, and one contained ephedrine.
CONCLUSION: These five patients presented with adverse reactions to "Herbal Ecstasy" ranging from minor to major. Knowledge of the possible mechanisms of toxicity will help plan therapy in cases of major toxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972312

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  3 in total

1.  A systematic review of the safety of kava extract in the treatment of anxiety.

Authors:  Clare Stevinson; Alyson Huntley; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients.

Authors:  K F Tam; D K L Cheng; T Y Ng; H Y S Ngan
Journal:  Support Care Cancer       Date:  2005-07-20       Impact factor: 3.603

3.  Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.

Authors:  Thomas M Habermann; Carrie A Thompson; Betsy R LaPlant; Brent A Bauer; Carol A Janney; Matthew M Clark; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Susan M Geyer; James R Cerhan
Journal:  Am J Hematol       Date:  2009-12       Impact factor: 10.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.